Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017
Operating activities
Net income	$ 104,541	$ 74,763
Adjustments to reconcile net income to net cash provided by operating activities:
Distributions from unconsolidated subsidiaries	7,830	10,933
Depreciation and amortization	98,495	80,872
Provision for bad debts	102	745
Equity in earnings of unconsolidated subsidiaries	(9,482)	(11,187)
Loss on extinguishment of debt	484	6,527
Gain on sale of assets and businesses	(6,980)	(9,523)
Stock compensation expense	10,911	9,270
Amortization of debt discount, premium and issuance costs	6,486	5,974
Deferred income taxes	(1,691)	(1,474)
Changes in operating assets and liabilities, net of effects of business combinations:
Accounts receivable	(5,774)	(140,949)
Other current assets	(3,011)	(5,557)
Other assets	6,684	4,621
Accounts payable	(5,462)	759
Accrued expenses	1,207	(4,833)
Income taxes	12,610	19,399
Net cash provided by (used in) operating activities	216,950	40,340
Investing activities
Business combinations, net of cash acquired	(517,704)	(18,508)
Purchases of property and equipment	(81,648)	(105,302)
Investment in businesses	(3,291)	(9,874)
Proceeds from sale of assets and businesses	6,672	34,552
Net cash provided by (used in) investing activities	(595,971)	(99,132)
Financing activities
Borrowings on revolving facilities	265,000	630,000
Payments on revolving facilities	(345,000)	(550,000)
Proceeds from term loans	779,904	1,139,487
Payments on term loans	(5,750)	(1,173,692)
Revolving facility debt issuance costs	(1,333)	(4,392)
Borrowings of other debt	19,928	9,444
Principal payments on other debt	(11,521)	(10,437)
Repurchase of common stock	(889)	(600)
Dividends paid to Holdings	0	0
Proceeds from exercise of stock options	1,620	963
Equity investment by Holdings	0	0
Decrease in overdrafts	(6,171)	(5,228)
Proceeds from issuance of non-controlling interests	2,926	3,553
Distributions to non-controlling interests	(301,213)	(5,536)
Net cash provided by (used in) financing activities	397,501	33,562
Net increase (decrease) in cash and cash equivalents	18,480	(25,230)
Cash and cash equivalents at beginning of period	122,549	99,029
Cash and cash equivalents at end of period	141,029	73,799
Supplemental Information
Cash paid for interest	97,338	76,650
Cash paid for taxes	22,480	27,626
Non-cash equity exchange for acquisition of U.S. HealthWorks	238,000	0
Select Medical Corporation
Operating activities
Net income	104,541	74,763
Adjustments to reconcile net income to net cash provided by operating activities:
Distributions from unconsolidated subsidiaries	7,830	10,933
Depreciation and amortization	98,495	80,872
Provision for bad debts	102	745
Equity in earnings of unconsolidated subsidiaries	(9,482)	(11,187)
Loss on extinguishment of debt	484	6,527
Gain on sale of assets and businesses	(6,980)	(9,523)
Stock compensation expense	10,911	9,270
Amortization of debt discount, premium and issuance costs	6,486	5,974
Deferred income taxes	(1,691)	(1,474)
Changes in operating assets and liabilities, net of effects of business combinations:
Accounts receivable	(5,774)	(140,949)
Other current assets	(3,011)	(5,557)
Other assets	6,684	4,621
Accounts payable	(5,462)	759
Accrued expenses	1,207	(4,833)
Income taxes	12,610	19,399
Net cash provided by (used in) operating activities	216,950	40,340
Investing activities
Business combinations, net of cash acquired	(517,704)	(18,508)
Purchases of property and equipment	(81,648)	(105,302)
Investment in businesses	(3,291)	(9,874)
Proceeds from sale of assets and businesses	6,672	34,552
Net cash provided by (used in) investing activities	(595,971)	(99,132)
Financing activities
Borrowings on revolving facilities	265,000	630,000
Payments on revolving facilities	(345,000)	(550,000)
Proceeds from term loans	779,904	1,139,487
Payments on term loans	(5,750)	(1,173,692)
Revolving facility debt issuance costs	(1,333)	(4,392)
Borrowings of other debt	19,928	9,444
Principal payments on other debt	(11,521)	(10,437)
Repurchase of common stock	0	0
Dividends paid to Holdings	(889)	(600)
Proceeds from exercise of stock options	0	0
Equity investment by Holdings	1,620	963
Decrease in overdrafts	(6,171)	(5,228)
Proceeds from issuance of non-controlling interests	2,926	3,553
Distributions to non-controlling interests	(301,213)	(5,536)
Net cash provided by (used in) financing activities	397,501	33,562
Net increase (decrease) in cash and cash equivalents	18,480	(25,230)
Cash and cash equivalents at beginning of period	122,549	99,029
Cash and cash equivalents at end of period	141,029	73,799
Supplemental Information
Cash paid for interest	97,338	76,650
Cash paid for taxes	22,480	27,626
Non-cash equity exchange for acquisition of U.S. HealthWorks	$ 238,000	$ 0